Concepedia

Publication | Closed Access

Cetuximab plus Gemcitabine-Oxaliplatin (GEMOX) in Patients with Refractory Advanced Intrahepatic Cholangiocarcinomas

DOI

99

Citations

22

References

2007

Year

Bernard Paule, Marie-Olga Herelle, Estelle Rage, Michel Ducreux, René Adam, Catherine Guettier, Marie‐Pierre Bralet
Oncology

Abstract

Even in the absence of EGFR gene amplification, cetuximab + GEMOX is a well-tolerated palliative treatment in patients with advanced CCA. Adding cetuximab circumvents tumor resistance to GEMOX.

References

YearCitations

Page 1